Skip to content
Screener

Charles River Laboratories CRL Gross margin

Discontinued — last reported Q1 '18

Gross margin at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
28.9%+0.7pp
Sotera Health logo
Sotera HealthSHC
55%-0.6pp
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
19.3%-0.4pp
IQVIA logo
IQVIAIQV
33%-1.3pp
Quest Diagnostics logo
Quest DiagnosticsDGX
33.1%+0.1pp
NeoGenomics logo
NeoGenomicsNEO
43.9%0.0pp

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.56B+70.1%
Enterprise value$15.36B+53.4%
P/S3.1×+1.3×

Profitability

See full
Operating margin13%-2.4pp
Net margin-6%—
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%—
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Calculated from Charles River Laboratories’s reported figures.

gross profit/total revenue=84.7%

Based on trailing twelve months.

The source filing: Charles River Laboratories’s 10-Q, filed May 7, 2019. Open the filing →

Filed
May 7, 2019
Fiscal quarter
Q1 FY2019
Calendar quarter
Q1 2019
Accession
0001100682-19-000008

FAQ

What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.